The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study
EuroIntervention 2017;12:2009-2017 published online January 2017. DOI: 10.4244/EIJ-D-16-00884
Per Grimfjärd1,2*, MD; David Erlinge3, MD, PhD; Sasha Koul3, MD, PhD; Bo Lagerqvist1,4, MD, PhD; Bodil Svennblad4, MSc, PhD; Christoph Varenhorst1,4, MD, PhD; Stefan K. James1,4, MD, PhD
1. Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; 2. Department of Cardiology, Västerås Hospital, Västerås, Sweden; 3. Department of Cardiology, Skåne University Hospital, Lund University, Lund, Sweden; 4. Uppsala Clinica
Aims: The aim of the study was to compare outcomes in unfractionated heparin (UFH) and bivalirudin-treated patients undergoing primary percutaneous coronary intervention (PPCI).